Codexis (CDXS) Asset Utilization Ratio (2011 - 2026)

Codexis' (CDXS) quarterly Asset Utilization Ratio came in at 0.56 in Q1 2026, up 57.18% year-on-year from 0.36 in Q1 2025, and up 8.78% quarter-over-quarter from 0.52 in Q4 2025.

Codexis (CDXS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Codexis' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.56 for Q1 2026.

  • On a quarterly basis, Asset Utilization Ratio rose 57.18% year-over-year to 0.56 in Q1 2026; TTM through Mar 2026 was 0.56, a 57.18% increase from a year earlier, with the FY2025 full-year figure at 0.47, up 14.12% from the prior year.
  • Asset Utilization Ratio climbed to 0.56 in Q1 2026 per CDXS's latest filing, from 0.52 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.57 in Q2 2022 and bottomed at 0.22 in Q4 2023.
  • The 5-year median for Asset Utilization Ratio is 0.4 (2025), against an average of 0.41.
  • Across the five-year window, Asset Utilization Ratio slumped 57.94% in 2023 and jumped 80.14% in 2024, its largest moves.
  • Year by year, Asset Utilization Ratio stood at 0.53 in 2022, then plunged by 57.94% to 0.22 in 2023, then surged by 80.14% to 0.4 in 2024, then increased by 29.71% to 0.52 in 2025, then grew by 8.78% to 0.56 in 2026.
  • Per Business Quant, the three latest CDXS Asset Utilization Ratio figures stand at 0.56 (Q1 2026), 0.52 (Q4 2025), and 0.4 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn 0.56

Historic Data

Download Data
DateValue
Mar 31, 2026 0.56
Dec 31, 2025 0.52
Sep 30, 2025 0.40
Jun 30, 2025 0.43
Mar 31, 2025 0.36
Dec 31, 2024 0.40
Sep 30, 2024 0.31
Jun 30, 2024 0.28
Mar 31, 2024 0.25
Dec 31, 2023 0.22
Sep 30, 2023 0.26
Jun 30, 2023 0.34
Mar 31, 2023 0.45
Dec 31, 2022 0.53
Sep 30, 2022 0.56
Jun 30, 2022 0.57
Mar 31, 2022 0.51
Dec 31, 2021 0.44
Sep 30, 2021 0.46
Jun 30, 2021 0.39